LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Начало・Списък с акции・Avita Therapeutics Inc

Avita Therapeutics Inc

Затворен

3.48 -1.69

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.4699999999999998

Максимум

3.51

Ключови измерители
By Trading Economics
Приходи	-3.3M -13M
Продажби	-1.4M 17M
EPS	-0.712
Марж на печалбата	-77.289
Служители	260
EBITDA	4M -8.1M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+85.71% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-12M 109M
Предишно отваряне	5.17
Предишно затваряне	3.48

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

8.83 / 9.77 Подкрепа & съпротива

Avita Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.12.2025 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Brookfield, GIC Agree $4.5 Billion Deal for Australia's National Storage -- Update

5.12.2025 г., 21:08 ч. UTC

Придобивния, сливания и поглъщания

Meta Platforms Buys AI-Device Maker Limitless

5.12.2025 г., 19:39 ч. UTC

Значими двигатели на пазара

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

5.12.2025 г., 19:17 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

7.12.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen -- Market Talk

7.12.2025 г., 23:05 ч. UTC

Пазарно говорене

RBA Set to Remain 'Emphatically' On Hold, Westpac Says -- Market Talk

7.12.2025 г., 22:18 ч. UTC

Пазарно говорене

RBA Set To Conclude Year With Hawkish Message -- Market Talk

6.12.2025 г., 16:52 ч. UTC

Придобивния, сливания и поглъщания

As Netflix Swoops In to Buy Warner Bros., We Revisit the Studio's Long, Twisted Journey -- Barrons.com

6.12.2025 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

Why Netflix Shareholders Aren't Thrilled to Acquire Warner Bros. -- Heard on the Street -- WSJ

6.12.2025 г., 02:38 ч. UTC

Придобивния, сливания и поглъщания

How a Netflix-Warner Deal Would Change Everything in Hollywood -- Again -- WSJ

5.12.2025 г., 21:59 ч. UTC

Придобивния, сливания и поглъщания

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

5.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Financial Services Roundup: Market Talk

5.12.2025 г., 21:50 ч. UTC

Придобивния, сливания и поглъщания

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

5.12.2025 г., 21:36 ч. UTC

Пазарно говорене

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

5.12.2025 г., 21:35 ч. UTC

Придобивния, сливания и поглъщания

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

5.12.2025 г., 21:26 ч. UTC

Придобивния, сливания и поглъщания

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

5.12.2025 г., 21:12 ч. UTC

Пазарно говорене

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

5.12.2025 г., 21:03 ч. UTC

Пазарно говорене

Печалби

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

5.12.2025 г., 21:01 ч. UTC

Пазарно говорене

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

5.12.2025 г., 20:43 ч. UTC

Придобивния, сливания и поглъщания

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

5.12.2025 г., 20:43 ч. UTC

Придобивния, сливания и поглъщания

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

5.12.2025 г., 20:42 ч. UTC

Придобивния, сливания и поглъщания

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

5.12.2025 г., 20:01 ч. UTC

Придобивния, сливания и поглъщания

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

5.12.2025 г., 19:44 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

5.12.2025 г., 19:44 ч. UTC

Пазарно говорене

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

5.12.2025 г., 19:39 ч. UTC

Пазарно говорене

Silver Climbs to a New Record High -- Market Talk

5.12.2025 г., 19:31 ч. UTC

Придобивния, сливания и поглъщания

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5.12.2025 г., 18:30 ч. UTC

Пазарно говорене

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

5.12.2025 г., 18:28 ч. UTC

Придобивния, сливания и поглъщания

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5.12.2025 г., 18:24 ч. UTC

Придобивния, сливания и поглъщания

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Avita Therapeutics Inc Прогноза

Ценова цел

By TipRanks

85.71% нагоре

12-месечна прогноза

Среден 6.5 USD 85.71%

Висок 11 USD

Нисък 3 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Avita Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Avita Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

8.83 / 9.77Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.